NCT04727437View on ClinicalTrials.gov

STOPping Anticoagulation for Isolated or Incidental Subsegmental Pulmonary Embolism

PHASE3UnknownINTERVENTIONAL
Enrollment

1,466

Participants

Timeline

Start Date

April 8, 2021

Primary Completion Date

July 31, 2023

Study Completion Date

May 31, 2024

Conditions
Subsegmental Pulmonary Embolism Nos
Interventions
OTHER

No treatment

Withholding anticoagulation for at least 3 months.

DRUG

Warfarin

anticoagulation drug given for at least 3 months.

DRUG

direct oral anticoagulants

anticoagulation drug given for at least 3 months.

DRUG

Low molecular weight heparin

anticoagulation drug, subcutaneous injection given for at least 3 months.

Trial Locations (1)

RH1 5RH

RECRUITING

Surrey & Sussex Healthcare NHS Trust, Redhill

Sponsors

Collaborators (1)

Cimar
All Listed Sponsors
collaborator

Royal United Hospitals Bath NHS Foundation Trust

OTHER

collaborator

Cimar

UNKNOWN

lead

University of Birmingham

OTHER